REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDINS

Details for Australian Patent Application No. 2003257588 (hide)

Owner SANTEN PHARMACEUTICAL CO., LTD.

Inventors HARA, Hideaki; NAKAJIMA, Tadashi; MATSUGI, Takeshi

Pub. Number AU-A-2003257588

PCT Number PCT/JP03/11004

PCT Pub. Number WO2004/019951

Priority 2002-250223 29.08.02 JP

Filing date 29 August 2003

Wipo publication date 19 March 2004

International Classifications

A61K 031/5575

A61K 031/5377

A61K 031/553 - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61P 027/06 Drugs for disorders of the senses

A61P 043/00 Drugs for specific purposes, not provided for in groups

A61K 045/06 Medicinal preparations containing active ingredients not provided for in groups

A61K 031/437

A61K 031/4409 - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 031/4725

Event Publications

6 November 2003 Complete Application Filed

  Priority application(s): 2002-250223 29.08.02 JP

6 May 2004 Application Open to Public Inspection

  Published as AU-A-2003257588

19 May 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003257589-REMEDY FOR INTEGRATION DYSFUNCTION SYNDROME

2003257587-METHOD OF EVALUATING DEGREE OF CANCERATION OF HUMAN-ORIGIN SPECIMEN